Gapping up
In reaction to earnings/guidance:
- QD +20.2%, CIEN +7.3%, FTI +1.1%, NDSN +0.8%
M&A news:
- BLL +19.9% (agrees to sell Chinese beverage can and end manufacturing facilities for approximately $225 million)
Other news:
- NBEV +11.5% (continued strength)
- UXIN +5.8% (following 20%+ move higher boosted by Taobao update and general strength in China names)
- AFL +4.4% (confirms that it is engaged in discussions with Japan Post regarding a potential minority investment in Aflac through open market purchases)
- YRIV +1.9% (provides details regarding Hindenburg's research report)
- ACB +1.5% (to invest CAD$10 mln in High Tide by way of brokered private placement)
- KTOS +1.4% (Kratos Defense and Security and Space Vector team receive $424 million multi-award contract for U.S. Air Force Sounding Rocket Program-4 )
- BYD +1.2% (light volume; authorizes new $100 mln share repurchase authorization)
- INCY +0.9% (Eli Lilly and Incyte announce that the FDA has granted Fast Track designation to baricitinib for the treatment of systemic lupus erythematosus) .
Analyst comments:
- GE +10.6% (upgraded to Neutral from Underweight at JP Morgan (long time bear on the name)
- IMMY +5.2% (initiated with a Buy at B. Riley FBR)
- ADC +2.8% (upgraded to Buy from Hold at Jefferies)
- FIVE +2.6% (upgraded to Buy from Neutral at Goldman)
- MRVL +2.1% (upgraded to Buy from Neutral at Citigroup)
- NKTR +1.7% (initiated with a Buy at Goldman)
- PG +0.9% (upgraded to Buy from Neutral at BofA/Merrill)
